The SelectSecure lead system (SSLS), which is composed of a thin lumenless, active-fixation lead and a deflectable catheter, is approved for use in Japan. This study aimed to evaluate the long-term clinical outcomes of right ventricular (RV) septal pacing with the SSLS along with the system's safety and electrical performance. A total of 129 patients were divided into the following 3 groups: the RV septal pacing with the SSLS group (SSP, n = 21); the RV septal pacing with the conventional lead group (Septal, n = 77); and the RV apical pacing with the conventional lead group (Apical, n = 31). All lead-related complications and pacing parameters during follow-up were compared among the groups. The clinical outcome was heart failure-associated hospitalization. The SSP and Septal groups showed significantly shorter paced QRS duration than the Apical group. During the follow-up for a mean of 49.5 ± 13.1 months, no lead-related complications occurred in any of the groups. A case of pericardial effusion occurred in the SSP group, but cardiac tamponade did not occur, and it spontaneously resolved. The ventricular pacing threshold after the follow-up period was higher in the SSP group than in the other 2 groups. There was no difference in the primary heart failure hospitalization among the 3 groups. The SSLS could be effective in producing a narrow QRS width with RV septal pacing, but its pacing threshold was higher than conventional leads in the chronic phase.
T he right ventricular (RV) apex has been the standard position for permanent ventricular pacing. However, RV apical pacing can result in myocardial protein dysregulation, 1) fibrosis and myofiber hypertrophy, 2) and electrical and mechanical dyssynchrony. 3) Several large clinical studies have shown that RV apical pacing with an assigned dual-chamber pacemaker had no significant effect on the risk of death, heart failure hospitalization, stroke, or atrial fibrillation. [4] [5] [6] [7] [8] Therefore, alternative RV non-apical pacing sites with a more synchronous ventricular contraction, such as the RV septum and RV outflow tract, were identified. [9] [10] [11] Superior hemodynamic effects have been reported with RV septal pacing or RV outflow tract pacing compared with RV apical pacing in the short term. 12, 13) However, several investigations comparing RV septal pacing with RV apical pacing have reported conflicting mid-to long-term outcome results. [14] [15] [16] [17] With regard to selecting the site for RV septal pacing, the standard approach by means of manually curved stylets has been challenging and may not provide the optimal position in some circumstances. With the SelectSecure model 3830 lead system (Medtronic Inc., Minneapolis, MN, USA), constructed with a thin lumenless pacing lead and delivery system using a deflectable catheter, it is possible to place leads in any position in alternate right atrial or ventricular sites. [18] [19] [20] [21] The aim of the present study was to evaluate longterm clinical outcome differences between patients treated with RV septal pacing using the SelectSecure lead system and those treated with RV septal or apical pacing using the conventional stylet-delivered pacing lead. In addition, the electrical performance and safety of the SelectSecure lead placed in the RV septum in adult patients without structural congenital heart disease was assessed.
Methods
Patient selection: Consecutive patients who underwent pacemaker implantation for the prevention or treatment of bradyarrhythmia at a single hospital between January 2011 and September 2013 were evaluated in this observa-Suzuki, ET AL tional, retrospective, case-control study. All patients gave their informed consent to participate in the study, which was approved by our institutional ethics committee (approval no. 23-166 on April 10, 2012). Study protocol: Patients implanted with a single chamber (VVI) or dual-chamber (DDD) pacemaker were evaluated. All patients were divided into the following 3 groups. Group 1 (SSP group), patients with the RV lead positioned at the RV septum using a lumenless 4.1-Fr diameter lead (Medtronic M3830), with a bipolar, steroideluting helical design with an 8.4-Fr diameter steerable peel-away catheter system (SelectSecure system, Medtronic Minneapolis, MN, USA). Group 2 (Septal group) and Group 3 (Apical group) were composed of patients who received the traditional stylet-delivered 4.8-6.96-Fr diameter leads, which were also bipolar, steroid-eluting, and active-fixation helical designs (Septal group patients had the RV lead positioned at the RV septum, while Apical group patients had the RV lead positioned at the RV apex). Ventricular pacing thresholds, R-wave amplitudes, ventricular pacing lead impedances, paced QRS duration, and procedure duration were measured at the time of implantation. Data on the electrical performance of the ventricular leads were collected during postoperative followup in the device clinic setting at 6 months, 12 months, and yearly thereafter. Lead-related complications, such as lead dislodgement, were also recorded. Echocardiographic recordings were obtained by investigators blinded to pacing site. Left ventricular end-diastolic volume (LVEDV) and left ventricular end-systolic volume (LVESV) were measured; left ventricular ejection fraction (LVEF) was calculated using Simpson's method. All measurements were taken at baseline and in patients with echocardiograms available at 42 months. The clinical outcome was hospitalization associated with heart failure. Implantation procedure: The RV pacing site was selected at the discretion of the implanting physician's clinical assessment. In all cases, a pacing lead was inserted into a right or left subclavian vein by percutaneous puncture. The SSP group used the SelectSecure system. The SelectSecure pacing lead was delivered through a 10-Fr deflectable catheter. This steerable catheter was guided to the RV over the guidewire and then deflected to a position at the RV septum by rotating the handle. The lead was fixed using 3-5 clockwise rotations at the RV septum. After the appropriate lead position was achieved, the deflectable delivery catheter-sheath was slit using standard technique. A conventional lead was positioned in the Septal and Apical groups using a hand-shaped stylet. The lead stylet of the Septal group was shaped like a J curve at the distal 6 cm and vertically folded at the terminal 1 cm. The final RV lead position was confirmed using the fluoroscopic view. A lead placed in the RV septum was imaged with a 45°-50°left anterior oblique view. A lead placed in the RV apex was imaged with a posteroanterior view (Figures 1-3) . A 12-lead electrocardiogram (ECG) was helpful in the diagnosis of the RV septal pacing. A negative deflection of ECG lead V1 and QRS morphology was positive at leads II and III. [22] [23] [24] The location of the RV leads was reviewed by an observer in a blinded manner. Statistical analysis: Data are reported as means ± SD. Statistical analysis was performed with one-way analysis of variance (ANOVA) or with Kruskal-Wallis ANOVA when assumptions of normality of the distribution or the homogeneity of variances were not verified. Cumulative event rate was estimated using the Kaplan-Meier method and compared using the log-rank test. Cox proportional hazard regression analysis was used for calculating the hazard ratio (HR) and 95% confidence interval (CI) for the influencing factors to the clinical event. Statistical significance was defined as P < 0.05. Statistical analyses were conducted using SPSS version 21 (SPSS, Inc., Chicago, IL).
Results
In this study, 129 patients (mean age 75.5 ± 9.8 years; 46.5% male) underwent pacemaker implantation. The SSP group, which included patients with a lead screwed into the ventricular septum by the SelectSecure system, accounted for 16.3%; the Septal group, which included patients with a common lead screwed into the ventricular septum, accounted for 59.7%; and the Apical group, which included patients with a common lead screwed into the apex, accounted for 24%. Clinical characteristics and the echocardiography results of each group are presented in Table I . Mean follow-up was 49.5 ± 13.1 months and proved similar in the 3 groups. There were no significant differences in the medical history and indications for pacemaker implantation. LVEF, LVESV, and LVEDV before implantation were similar among the 3 groups. Table II shows the type of pacemaker, DDD or VVI, paced QRS duration, complications, and the change of pacing ratio by year among the 3 groups.
LONG-TERM OUTCOMES OF SELECTSECURE LEAD SYSTEM
DDDs were implanted in 81% of the SSP group, 84.4% of the Septal group, and 71% of the Apical group; there was no significant difference among the groups. There was also no significant difference in the change of pacing ratio among the groups. The SSP and Septal groups showed significantly shorter paced QRS duration than the Apical group (136.2 ± 16.6 ms, 144.9 ± 15.4 ms, and 170.6 ± 20.8 ms from SSP, Septal, and Apical groups, respectively; P < 0.01). We compared the paced QRS duration between the SSP and Septal groups and found that the QRS duration in the SSP group became relatively narrower than in the Septal group, but there no significant difference was noted. In the operation time, from ventricular pacing lead insertion to finishing to fix that lead, the SSP group showed significantly longer than the other 2 groups. In one SSP group patient, a pericardial effusion occurred, but it did not lead to serious complications that Suzuki, ET AL required additional treatment. This complication occurred intraoperatively when the deflectable sheath of the SelectSecure system was advanced to the RV and the distal end portion of the sheath was attached to the RV myocardial wall. During the follow-up period, no lead-related complications, such as dislodgement or disconnection of the ventricular lead, occurred in any of the groups. Table III shows the changes of RV lead electrical parameters and ventricular lead performance. There was no significant difference in R-wave amplitudes among the 3 groups over the 3 years of follow-up. Six months after the operation, the SSP group showed a meaningful rise in the ventricular pacing threshold compared with the other 2 groups and higher impedance than the Septal group, but these differences in the SSP group did not cause clinical problems.
A total of 20 heart failure hospitalizations occurred during follow-up in the 3 groups, 2 patients from the SSP group (9.5%), 11 patients from the Septal group (14.3%), 7 patients from the Apical group (22.6%). Figure 4 shows that there was no significant difference in the rate of heart failure hospitalization among the 3 groups. Cox proportional hazard regression analyses showed that the reduction of hemoglobin level (HR, 0.75; 95% CI, 0.57-0.99; P = 0.039) and the VVI pacemaker implantation (HR, 3.25; 95% CI, 1.15-9.19; P = 0.026) were significant predictors of heart failure hospitalization (Table IV) .
Discussion
This study found that the SSP group showed significantly shorter paced QRS duration than the Apical group and showed higher ventricular pacing threshold after the follow-up period than the other 2 groups. With respect to changes in electrical parameters, especially the ventricular pacing threshold, the SSP group showed a significant in-LONG-TERM OUTCOMES OF SELECTSECURE LEAD SYSTEM crease compared with the other 2 groups, the Septal and Apical groups, but this did not lead to clinical complications. Besides, we think this lead may be dislodged from the distal attachment site easily compared with the other 2 groups. For this reason, it is considered that inflammation and fibrosis of the part in contact with the electrode strongly occurred due to the fact that the operator consciously applied lead rotation slightly strongly when fixing the lead. Long-term follow-up is required to check whether the threshold continuously rises. Operation time was significantly longer in the SSP group than in the other 2 groups. Several studies have shown that long operation time caused serious infections.
25)
The SSP and Septal groups showed significantly shorter paced QRS duration than the Apical group. Some studies reported electrical or functional dyssynchrony caused by the RV pacing leading to longer paced QRS duration. 8, 26, 27) This study showed no significant differences in LVEF, LVESV, and LVEDV on echocardiography in the event of heart failure hospitalization. In the present study, the RV pacing rate was low in each group. If only the cases with higher RV pacing rate were selected and examined, there was a possibility that the pacing rate became a significant risk factor for heart failure hospitalization. Some reports investigated the clinical event incidence by comparing RV pacing QRS duration and showed that narrow pacing QRS prevented clinical events. In these reports, the follow-up periods were longer than in the present study. 28) Therefore, some significant differences in heart failure hospitalization and cardiovascular diseaserelated mortality may be observed among the groups if the follow-up period were to be prolonged.
The SelectSecure system in which the screw is placed using a deflectable sheath is more helpful in challenging anatomical situations (ex. dilated right atrium or tricuspid stenosis) than the conventional screw-in pacing lead, so this system will be selected preferentially in such cases. From the viewpoint of preventing infection with cardiac device implantation, the ease of removing devices or pacing leads is important 29) . In this study, no patients required removal of a device or leads. SelectSecure system pacing leads may be useful when they need to be removed 30) because the pacing leads have a simple internal structure such that there is no central lumen to deliver a stylet and various tools are not needed for removal. Therefore, the use of these leads is expected in cases with a high risk of infection, as in dialysis and steroid-treated patients.
Outside Japan, this system has recently been used for clinical permanent His bundle pacing. 31, 32) In Japan, this system's pacing lead has recently become compatible with magnetic resonance imaging. Therefore, this system will become more popular and common in clinical practice. Limitations: First, the main limitation of this study was that it was an observational retrospective analysis. Second, it was a single-center study, with a smaller number of SSP group patients compared to Septal group patients in both groups with RV septal pacing. A large multicenter, randomized study in patients requiring a SelectSecure system for RV septal pacing would be necessary for confirming the results. In addition, since there was no rule for the selection of leads, there may have been some bias in the selection of the SelectSecure system.
Conclusions
This study suggests that the SelectSecure system could be safe and effective in producing a narrow QRS width with RV septal pacing, but its pacing threshold was higher than conventional screw-in leads in the chronic phase. There was no significant difference in the rate of heart failure hospitalization among the 3 groups.
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